- Report
- August 2024
- 200 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- April 2024
- 198 Pages
Global
From €3212EUR$3,600USD£2,832GBP
- Report
- February 2022
- 602 Pages
Europe
From €8026EUR$8,995USD£7,077GBP
- Report
- November 2019
China
From €7134EUR$7,995USD£6,290GBP
- Report
- October 2024
- 114 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- August 2024
- 98 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Book
- October 2024
North America
- Book
- May 2024
North America
- Book
- December 2018
North America
- Book
- August 2018
Asia Pacific

The Urinary Tract Infection (UTI) market is a subset of the Urology and Nephrology market. UTIs are caused by bacteria entering the urinary tract, and can cause pain, burning, and frequent urination. Treatment typically involves antibiotics, and in some cases, hospitalization. The market is driven by the increasing prevalence of UTIs, as well as the aging population and the rise of antibiotic-resistant bacteria.
The market is composed of a variety of products, including antibiotics, urinary catheters, and other medical devices. Additionally, there are a number of services, such as diagnostic tests, hospitalization, and outpatient care.
Some companies in the UTI market include Astellas Pharma, Pfizer, Merck, and Allergan. Other companies include C.R. Bard, B. Braun, and Cook Medical. Show Less Read more